Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

An Interview with Expert Clinician Dr. Fred Wigley

Jason Liebowitz, MD, FACR  |  Issue: January 2024  |  January 10, 2024

Dr. Wigley: I have learned so many lessons from patients that have tuned my skills and made me a better doctor. In fact, every patient sends a message and an experience that fills my list of how to be a good doctor. Here are a couple of examples:

Once, when in medical school, we had a rotation at the Mayo Clinic in Florida where interns worked with residents to provide healthcare to a community with no local doctors. We cared for a patient with a large staphylococcal abscess. Periodically, an attending from the university would come and make rounds to teach and to actually see patients. One visit was from an infectious disease expert from Gainesville, who was a world-renowned expert on staphylococcal infections. He examined the patient’s abscess and made some recommendations. The patient looked up and said: “Am I going to see my doctor today?”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lesson: Your relationship with the patient comforts the patient more than your credentials.

Another lesson was from a young woman with end-stage scleroderma lung disease and secondary pulmonary hypertension on high-flow oxygen. In the last days of her life, she looked up at me and said: “My lungs are no good, but I feel fine. I am happy and content with my life and family.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Lesson: Recognize that, despite unrelenting disease, patients overcome distress for the important elements of their life. Give them that opportunity.

A third lesson was from a gentleman with rheumatoid arthritis. It was a time before biologics were available, but with injection therapy and then methotrexate, I controlled his disease. I was very pleased with his status and level of function. He came for a follow-up and gave me a self-portrait. The painting portrayed sadness and distress; he was dressed in a striped, prison-like shirt. I talked with him and realized there were deep emotional issues I had not addressed.

Lesson: I had treated the disease, but not the patient.

TR: What skills, habits, or experiences have you found most helpful in finding the right diagnosis in medical mystery cases that heretofore had been unsolved?

Dr. Wigley: The major skill is leaning on experience. Once I see something I try to learn all about it so that next time it is encountered I have expertise to apply.

I listen carefully to the patient and then clarify concerns so that all of the patient’s symptoms are clear and understood. I try to do a careful exam that I customize for the specific issue (e.g., an expanded neurological exam, if needed), but then do a pre-designed survey of all systems. I figure if you do not look, you do not see. Once, I found an asymptomatic melanoma on the sole of a foot that I would have missed if I had not removed the socks.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionProfiles Tagged with:Dr. Fred WigleyRole Models in Rheumatology

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Targeted Therapy for Scleroderma Fibrosis

    October 11, 2016

    Scleroderma, or systemic sclerosis (SSc), is an autoimmune disease characterized by vasculopathy and fibrosis. Although relatively rare, with a prevalence in North America of approximately 300 per 1 million people, SSc is associated with significant morbidity and high rates of mortality.1 Patients with scleroderma have four times greater mortality than age- and sex-matched controls, with…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences